Advisory Board and Editors Molecular Biology
Amaresh Chandra Panda
Dr. Panda obtained his Ph.D. in Biotechnology from National Centre for Cell Science, University of Pune, India. He worked as a Postdoctoral Fellow for five years at the National Institute on Aging, National Institutes of Health (NIH), Baltimore, USA. He also worked as an Assistant Scientist at the University of Miami, Miami, USA, and as a Postdoctoral Fellow at the University of Colorado, Denver, USA. His studies have uncovered new mechanistic details of the post-transcriptional regulation by RNA-binding proteins, microRNAs, and circular RNAs in physiological processes, including insulin production, myogenesis, and cellular senescence. In 2019, he was awarded the prestigious Intermediate Fellowship by Wellcome Trust/DBT India Alliance. Currently, he is working as a Scientist-D at ILS Bhubaneswar under the Department of Biotechnology, Government of India. His research group at ILS is working to understand the role of poorly characterized circRNAs in muscle regeneration and insulin biosynthesis.
Anurag N Paranjape
Passionate about understanding the mechanisms governing cancer metastasis with a hope of finding new targetable pathways. Have worked on breast cancer stem cells, EMT, prostate cancer stem cells, breast cancer brain metastasis, and blood-brain barriers.
Tanya Parish
Tanya Parish a Principal Investigator in the Center for Global Infectious Disease Research, Seattle Children’s Research Institute and a Professor in the Department of Pediatrics, University of Washington School of Medicine.
Her work focuses on the discovery of new drugs that are effective at curing drug-sensitive and drug-resistant tuberculosis with the added goal of shortening the time it takes to cure disease. This encompasses a range of early stage drug discovery including drug target identification and validation, high throughput screening and medicinal chemistry. In addition, her group works to understand the pathogenic mechanisms and basic biology of the global pathogen Mycobacterium tuberculosis and using this information to inform drug discovery.
Tanya is a microbiologist by training, with a background in mycobacteriology. She received her PhD at the National Institute for Medical Research investigating gene regulation in mycobacteria followed by postdoctoral research at the London School of Hygiene & Tropical Medicine studying several facets of the biology of M. tuberculosis. She previously held an academic post as Professor of Mycobacteriology at Barts and the London School of Medicine and Dentistry, and was a Senior Vice President (Drug Discovery) at the Infectious Disease Research Institue.
Tanya has edited several books on mycobacteria and published numerous papers on the basic biology and genetics of M. tuberculosis.
Anup Singh Pathania
Dr. Anup Pathania is an Assistant Professor at the University of Nebraska Medical Center (UNMC).
His research interests include non-coding RNAs in cancer, pharmacology, and immunology. He is currently investigating the underlying mechanisms in the stabilization of PD-L1 by exosomal non-coding RNAs in neuroblastoma cells within the tumor microenvironment.
Santosh K Patnaik
After completing my training as a physician, I enrolled in a Ph.D. program to become a biomedical researcher. My doctoral training, in the broad field of biochemistry, and cell and molecular biology, focused on mechanisms of glycosylation, which is altered in diseases such as cancer and neuromuscular dystrophy. My current primary research focus is on RNA editing, and on microRNAs.
George N. Pavlakis
MD, University of Athens, Greece
PhD, Syracuse University, NY
Chief of the Human Retrovirus Section of the National Cancer Institute, USA
Interests: HIV pathogenesis, Molecular Biology, gene regulation, Biotechnology, protein engineering, cytokines, Immunotherapy, Vaccines, Nucleic acid vaccines, gene therapy
José E Pérez-Ortín
José E Pérez-Ortín is full Professor at the University of València since 2008. He leads a research group on Yeast Funtional Genomics
Kevin Petrie
I obtained my PhD from the Institute of Cancer Research in London spent a further 10 years there as a postdoctoral fellow and Staff Scientist. I am currently a Lecturer in Molecular Biology at the University of Stirling in Scotland. My principal research interest is translational oncology, with a focus on epigenetics.
Ulrich Pfeffer
Ulrich Pfeffer - born on January 23rd, 1958 in Berlin, Fed. Rep of Germany
Education:
1976-1983 Study of Biology, Free University Berlin
1983 Master degree, Free University Berlin
1987 PhD Free University Berlin, Prof. Dr. E-R. Lochmann
2013 Habilitation full professor in Molecular Biology and General Pathology, Ministry of Education, University and Research
Scientific work:
2013-today Senior Staff Scientist, Molecular Pathology, Ospedale Policlinico San Martino, Genova, Head: Franco Fais
2010-2013 Director, Division of Integrated Molecular Pathology, National Cancer Research Institute (IST)
2004-2010 Section Chief, IST, Functional Genomics.
1999-2004 Senior Staff Scientist, IST, Laboratory Molecular Oncology, Head: Dr. A. Albini
1993-1999 Staff scientist, tenure; IST, Genoa, Laboratory of Molecular Biology, Head: Prof. Giorgio Vidali (from 1996-1999: Dr. G. Levi)
1988-1993 Postdoctoral fellow, National Cancer Research Institute (IST), Genoa, Laboratory of Molecular Biology, Head: Prof. G. Vidali
1985-1987 Research fellow , same lab
1984 Research fellow, University of Genoa
Teaching:
2017- today Contract professor for bioinformatics, Biotechnology Bachelor course, University of Genoa
2006-2015 Contract professor for bioinformatics, Biotechnology Master course, University of Genoa
2006-2013 Member of the Board, PhD School in Biotechnology, Lecturer in bioinformatics, University of Genoa
Paripok Phitsuwan
Dr. Paripok Phitsuwan is Assistant Professor in the Division of Biochemical Technology at King Mongkut's Univeristy of Technology, Thonburi.
Dr. Phitsuwan's research focuses on biomass conversion and processing, particularly lignin valorization. He is interested in carbohydrate and lignin active enzymes and their applications in biotechnology-relevant industries and environmental remediation.
Brett E Pickett
Dr. Brett Pickett is an Assistant Professor in the Microbiology and Molecular Biology Department at Brigham Young University. He completed his B.S degree in Microbiology from BYU in 2005, his Ph.D. training in Microbiology at the University of Alabama at Birmingham, and his postdoctoral training in Pathology at the University of Texas Southwestern Medical Center at Dallas. He then obtained additional experience in industry, and at the J. Craig Venter Institute, where he led investigative studies in viral comparative genomics and the human transcriptional response during viral infection. His research develops data mining methods, applies machine learning techniques, and use advanced statistical workflows to better understand how human cells respond during infection.
Xavier Pochon
Team Leader, Molecular Surveillance, Biosecurity Group, Cawthron Institute, New Zealand.
Associate Professor, Institute of Marine Science, University of Auckland, New Zealand.
My research at the Cawthron Institute is highly applied and consist of developing multi-trophic molecular tools for environmental monitoring of marine industries (e.g. aquaculture farms, marine biosecurity in ports and marinas, and deep-sea exploration).
At the University of Auckland, I combine 'real-world' and 'blue-sky' research applications, including; i) investigating functional underpinnings of Symbiodiniaceae in coral reef ecosystems, ii) characterizing microbiomes in aquaculture and natural settings, iii) measuring eDNA and eRNA decay rates in marine invertebrates and vertebrates, iv) studying preferential settlement of marine invasive species associated with marine plastic debris, and v) exploring the diversity and dynamics of open-ocean plankton communities in the Pacific and beyond.